A natural HIV p17 protein variant up-regulates the LMP-1 EBV oncoprotein and promotes the growth of EBV-infected B-lymphocytes: Implications for EBV-driven lymphomagenesis in the HIV setting

International Journal of Cancer

Volumn 137, Issue 6, 2015, Pages 1374-1385

  Martorelli, Debora ^a   Muraro, Elena ^a   Mastorci, Katy ^a   Dal Col, Jessica ^a   Faè, Damiana Antonia ^a   Furlan, Chiara ^a,b   Giagulli, Cinzia ^b   Caccuri, Francesca ^b   Rusnati, Marco ^b   Fiorentini, Simona ^b   Carbone, Antonino ^a   Caruso, Arnaldo ^b   Dolcetti, Riccardo ^a  

^a CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

^b UNIVERSITY OF BRESCIA   (Italy)

Author keywords

Epstein Barr virus; HIV p17; lymphoma

Indexed keywords

CHEMOKINE RECEPTOR CXCR2; CYCLIN D2; CYCLIN D3; HUMAN IMMUNODEFICIENCY VIRUS P17 MATRIX PROTEIN; INTERLEUKIN 6; LATENT MEMBRANE PROTEIN 1 EPSTEIN BARR VIRUS ONCOPROTEIN; MATRIX PROTEIN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; ONCOPROTEIN; PROTEIN KINASE B; PROTEIN P17; STAT3 PROTEIN; UNCLASSIFIED DRUG; EBV-ASSOCIATED MEMBRANE ANTIGEN, EPSTEIN-BARR VIRUS; VIRUS PROTEIN;

ARTICLE; B LYMPHOCYTE; CARCINOGENESIS; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME ACTIVATION; EPSTEIN BARR VIRUS INFECTION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; LYMPHOMAGENESIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; UPREGULATION; CELL LINE; EPSTEIN BARR VIRUS; GENETICS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE ACTIVATION; METABOLISM; TRANSCRIPTION INITIATION; VIROLOGY;

B-LYMPHOCYTES; CELL LINE; CYCLIN D2; CYCLIN D3; EPSTEIN-BARR VIRUS INFECTIONS; HERPESVIRUS 4, HUMAN; HIV INFECTIONS; HUMANS; INTERLEUKIN-6; LYMPHOCYTE ACTIVATION; ONCOGENE PROTEINS; RECEPTORS, INTERLEUKIN-8B; RNA, MESSENGER; SIGNAL TRANSDUCTION; TRANSCRIPTIONAL ACTIVATION; UP-REGULATION; VIRAL MATRIX PROTEINS; VIRAL PROTEINS;

EID: 84936846909     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.29494     Document Type: Article

References (41)

1. Gloghini A, Dolcetti R, Carbone A,. Lymphomas occurring specifically in HIV-infected patients: from pathogenesis to pathology. Semin Cancer Biol 2013; 23: 457-67.
2. Grogg KL, Miller RF, Dogan A,. HIV infection and lymphoma. J Clin Pathol 2007; 60: 1365-72.
3. Grulich AE, van Leeuwen MT, Falster MO, et al., Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis. Lancet 2007; 370: 59-67.
4. Rubinstein PG, Aboulafia DM, Zloza A,. Malignancies in HIV/AIDS: from epidemiology to therapeutic challenges. AIDS 2014; 28: 453-65.
5. Simard EP, Pfeiffer RM, Engels EA,. Cumulative incidence of cancer among individuals with acquired immunodeficiency syndrome in the United States. Cancer 2011; 117: 1089-96.
6. Dolcetti R, Dal Col J, Martorelli D, et al., Interplay among viral antigens, cellular pathways and tumor microenvironment in the pathogenesis of EBV-driven lymphomas. Semin Cancer Biol 2013; 23: 441-56.
7. Kilger E, Kieser A, Baumann M, et al., Epstein-Barr virus-mediated B-cell proliferation is dependent upon latent membrane protein 1, which simulates an activated CD40 receptor. EMBO J 1998; 17: 1700-9.
8. Kulwichit W, Edwards RH, Davenport EM, et al., Expression of the Epstein-Barr virus latent membrane protein 1 induces B cell lymphoma in transgenic mice. Proc Natl Acad Sci U S A 1998; 95: 11963-8.
9. Kuppers R, Engert A, Hansmann ML,. Hodgkin lymphoma. J Clin Invest 2012; 122: 3439-47.
10. Molyneux EM, Rochford R, Griffin B, et al., Burkitt's lymphoma. Lancet 2012; 379: 1234-44.
11. Rickinson AB,. Co-infections, inflammation and oncogenesis: future directions for EBV research. Semin Cancer Biol 2014; 26C: 99-115.
12. Fiorentini S, Riboldi E, Facchetti F, et al., HIV-1 matrix protein p17 induces human plasmacytoid dendritic cells to acquire a migratory immature cell phenotype. Proc Natl Acad Sci U S A 2008; 105: 3867-72.
13. Fiorentini S, Marini E, Caracciolo S, et al., Functions of the HIV-1 matrix protein p17. New Microbiol 2006; 29: 1-10.
14. Freed EO,. HIV-1 gag proteins: diverse functions in the virus life cycle. Virology 1998; 251: 1-15.
15. Popovic M, Tenner-Racz K, Pelser C, et al,. Persistence of HIV-1 structural proteins and glycoproteins in lymph nodes of patients under highly active antiretroviral therapy. Proc Natl Acad Sci U S A 2005; 102: 14807-12.
16. Caccuri F, Giagulli C, Bugatti A, et al., HIV-1 matrix protein p17 promotes angiogenesis via chemokine receptors CXCR1 and CXCR2. Proc Natl Acad Sci U S A 2012; 109: 14580-5.
17. Giagulli C, Magiera AK, Bugatti A, et al., HIV-1 matrix protein p17 binds to the IL-8 receptor CXCR1 and shows IL-8-like chemokine activity on monocytes through rho/ROCK activation. Blood 2012; 119: 2274-83.
18. Giagulli C, Marsico S, Magiera AK, et al., Opposite effects of HIV-1 p17 variants on PTEN activation and cell growth in B cells. PLoS One 2011; 6: e17831.
19. Deutsch AJ, Aigelsreiter A, Steinbauer E, et al., Distinct signatures of B-cell homeostatic and activation-dependent chemokine receptors in the development and progression of extragastric MALT lymphomas. J Pathol 2008; 215: 431-44.
20. Young LS, Rickinson AB,. Epstein-Barr virus: 40 years on. Nat Rev Cancer 2004; 4: 757-68.
21. Ruvinsky I, Meyuhas O,. Ribosomal protein S6 phosphorylation: from protein synthesis to cell size. Trends Biochem Sci 2006; 31: 342-8.
22. Feniger-Barish R, Belkin D, Zaslaver A, et al., GCP-2-induced internalization of IL-8 receptors: hierarchical relationships between GCP-2 and other ELR(+)-CXC chemokines and mechanisms regulating CXCR2 internalization and recycling. Blood 2000; 95: 1551-9.
23. Doglioni C, Chiarelli C, Macri E, et al., Cyclin D3 expression in normal, reactive and neoplastic tissues. J Pathol 1998; 185: 159-66.
24. Solvason N, Wu WW, Parry D, et al., Cyclin D2 is essential for BCR-mediated proliferation and CD5 B cell development. Int Immunol 2000; 12: 631-8.
25. Teramoto N, Pokrovskaja K, Szekely L, et al., Expression of cyclin D2 and D3 in lymphoid lesions. Int J Cancer 1999; 81: 543-50.
26. Burger R,. Impact of interleukin-6 in hematological malignancies. Transfus Med Hemother 2013; 40: 336-43.
27. Mauray S, Fuzzati-Armentero MT, Trouillet P, et al., Epstein-Barr virus-dependent lymphoproliferative disease: critical role of IL-6. Eur J Immunol 2000; 30: 2065-73.
28. Vendrame E, Hussain SK, Breen EC, et al., Serum levels of cytokines and biomarkers for inflammation and immune activation, and HIV-associated non-Hodgkin B-cell lymphoma risk. Cancer Epidemiol Biomarkers Prev 2014; 23: 343-9.
29. Jones RJ, Seaman WT, Feng WH, et al., Roles of lytic viral infection and IL-6 in early versus late passage lymphoblastoid cell lines and EBV-associated lymphoproliferative disease. Int J Cancer 2007; 121: 1274-81.
30. Kelly G, Bell A, Rickinson A,. Epstein-Barr virus-associated Burkitt lymphomagenesis selects for downregulation of the nuclear antigen EBNA2. Nat Med 2002; 8: 1098-104.
31. Shair KH, Bendt KM, Edwards RH, et al., EBV latent membrane protein 1 activates akt, NFkappaB, and Stat3 in B cell lymphomas. PLoS Pathog 2007; 3: e166.
32. Zhang L, Hong K, Zhang J, et al., Multiple signal transducers and activators of transcription are induced by EBV LMP-1. Virology 2004; 323: 141-52.
33. Brennan P, Mehl AM, Jones M, et al., Phosphatidylinositol 3-kinase is essential for the proliferation of lymphoblastoid cells. Oncogene 2002; 21: 1263-71.
34. Bromberg J, Darnell JE, Jr,. The role of STATs in transcriptional control and their impact on cellular function. Oncogene 2000; 19: 2468-73.
35. Snyder M, Huang XY, Zhang JJ,. Identification of novel direct Stat3 target genes for control of growth and differentiation. J Biol Chem 2008; 283: 3791-8.
36. Diehl JA, Cheng M, Roussel MF, et al., Glycogen synthase kinase-3beta regulates cyclin D1 proteolysis and subcellular localization. Genes Dev 1998; 12: 3499-511.
37. Naderi S, Gutzkow KB, Lahne HU, et al., cAMP-induced degradation of cyclin D3 through association with GSK-3beta. J Cell Sci 2004; 117: 3769-83.
38. Giombini E, Dolcetti R, Caccuri F, et al., Detection of HIV-1 matrix protein p17 quasispecies variants in plasma of chronic HIV-1-infected patients by ultra-deep pyrosequencing. J Acquir Immune Defic Syndr 2014; 66; 332-339.
39. Bonnet F, Jouvencel AC, Parrens M, et al., A longitudinal and prospective study of Epstein-Barr virus load in AIDS-related non-Hodgkin lymphoma. J Clin Virol 2006; 36: 258-63.
40. Leruez-Ville M, Seng R, Morand P, et al., Blood Epstein-Barr virus DNA load and risk of progression to AIDS-related systemic B lymphoma. HIV Med 2012; 13: 479-87.
41. Van BD, Wolthers KC, Hovenkamp E, et al., Absolute level of Epstein-Barr virus DNA in human immunodeficiency virus type 1 infection is not predictive of AIDS-related non-Hodgkin lymphoma. J Infect Dis 2002; 186: 405-9.